Cleared Traditional

K921937 - NOVA NUCLEUS CLINICAL CHEMICAL SYST, MODIFICATION

K921937 is an FDA 510(k) clearance for NOVA NUCLEUS CLINICAL CHEMICAL SYST, manufactured by Nova Biomedical Corp.. The device is a Class 2 Chemistry device with product code JGS cleared through the Traditional 510(k) pathway after a 94-day FDA review.

K921937 · Nova Biomedical Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1992
Decision
94d
Days
Class 2
Risk

K921937 is an FDA 510(k) clearance for the NOVA NUCLEUS CLINICAL CHEMICAL SYST, MODIFICATION. Classified as Electrode, Ion Specific, Sodium (product code JGS), Class II - Special Controls.

Submitted by Nova Biomedical Corp. (Walham, US). The FDA issued a Cleared decision on July 27, 1992 after a review of 94 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1665 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Nova Biomedical Corp. devices

FDA 510(k) Submission Details - K921937

510(k) Number K921937 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 24, 1992
Decision Date July 27, 1992
Days to Decision 94 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d slower than avg
Panel avg: 88d · This submission: 94d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JGS Device Classification - Class 2, Special Controls

Product Code JGS Electrode, Ion Specific, Sodium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1665
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JGS Electrode, Ion Specific, Sodium

All 133
Devices cleared under the same product code (JGS) and FDA review panel - the closest regulatory comparables to K921937.
NOVA 8 CRT ANALYZER
K924547 · Nova Biomedical Corp. · Jan 1993
KODAK EKTACHEM CLINICAL CHEMISTRY SLIDES (NAIL)
K924471 · Eastman Kodak Company · Nov 1992
ANALYZER: NOVA 10 CRT ANALYZER & QUALI CONT MATER
K923806 · Nova Biomedical Corp. · Sep 1992
OLYMPUS ISE MODULE
K921718 · Olympus Corp. · Jul 1992
NOVA 14 NA/K/CL/GLU/BUN ANALYZER
K922215 · Nova Biomedical Corp. · Jul 1992
NOVA 4 NA/K/C1/TCO2/LI ANALYZER
K915176 · Nova Biomedical Corp. · Jan 1992